Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Total article views   HTML views PDF downloads Totals
14,221 Dovepress* 11,654+ 1,588 13,242
PubMed Central* 2,567 302 2,869
Totals 14,221 1,890 16,111
*Since 1 June 2018
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 5 7

View citations on PubMed Central and Google Scholar